1. A Case of Pneumothorax after Treatment with Lenvatinib for Anaplastic Thyroid Cancer with Lung Metastasis. (28th March 2018) Authors: Yamazaki, Haruhiko; Iwasaki, Hiroyuki; Yamashita, Toshinari; Yoshida, Tatsuya; Suganuma, Nobuyasu; Yamanaka, Takashi; Masudo, Katsuhiko; Nakayama, Hirotaka; Kohagura, Kaori; Rino, Yasushi; Masuda, Munetaka Other Names: Broom John Academic Editor. Journal: Case reports in endocrinology Issue: Volume 2018(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A case of undifferentiated pleomorphic sarcoma of the breast with lung and bone metastases. (2018) Authors: Yamazaki, Haruhiko; Shimizu, Satoru; Yoshida, Tatsuya; Suganuma, Nobuyasu; Yamanaka, Takashi; Yamashita, Toshinari; Rino, Yasushi; Masuda, Munetaka Journal: International journal of surgery case reports Issue: Volume 51(2018) Page Start: 143 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. A phase II trial of prophylactic olanzapine combined with palonosetron and dexamethasone for preventing nausea and vomiting induced by cisplatin. Issue 3 (31st March 2016) Authors: Maeda, Akimitsu; Ura, Takashi; Asano, Chisa; Haegawa, Ikue; Nomura, Motoo; Komori, Azusa; Narita, Yukiya; Taniguchi, Hiroya; Kadowaki, Shigenori; Muro, Kei; Horio, Yoshitsugu; Yoshida, Tatsuya; Oze, Isao; Kajita, Masaki; Mizutani, Akiyoshi Journal: Asia-Pacific journal of clinical oncology Issue: Volume 12:Issue 3(2016) Page Start: 254 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Aldehyde dehydrogenase 1 expression in cancer cells could have prognostic value for patients with non‐small cell lung cancer who are treated with neoadjuvant therapy: Identification of prognostic microenvironmental factors after chemoradiation. (December 2013) Authors: Zenke, Yoshitaka; Ishii, Genichiro; Ohe, Yuichiro; Kaseda, Kaoru; Yoshida, Tatsuya; Matsumoto, Shingo; Umemura, Shigeki; Yoh, Kiyotaka; Niho, Seiji; Goto, Koichi; Ohmatsu, Hironobu; Kuwata, Takeshi; Nagai, Kanji; Ochiai, Atsushi Journal: Pathology international Issue: Volume 63:Number 12(2013:Dec.) Page Start: 599 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Association between serum level soluble programmed cell death ligand 1 and prognosis in patients with non‐small cell lung cancer treated with anti‐PD‐1 antibody. Issue 12 (27th October 2020) Authors: Murakami, Shuji; Shibaki, Ryota; Matsumoto, Yuji; Yoshida, Tatsuya; Goto, Yasushi; Kanda, Shintaro; Horinouchi, Hidehito; Fujiwara, Yutaka; Yamamoto, Noboru; Ohe, Yuichiro Journal: Thoracic cancer Issue: Volume 11:Issue 12(2020) Page Start: 3585 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Baseline PD-L1 expression and tumour-infiltrated lymphocyte status predict the efficacy of durvalumab consolidation therapy after chemoradiotherapy in unresectable locally advanced patients with non-small-cell lung cancer. (February 2022) Authors: Shirasawa, Masayuki; Yoshida, Tatsuya; Imabayashi, Tatsuya; Okuma, Kae; Matsumoto, Yuji; Masuda, Ken; Shinno, Yuki; Okuma, Yusuke; Goto, Yasushi; Horinouchi, Hidehito; Tsuchida, Takaaki; Yamamoto, Noboru; Nakayama, Yuko; Watanabe, Shun-ichi; Motoi, Noriko; Ohe, Yuichiro Journal: European journal of cancer Issue: Volume 162(2022) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. C reactive protein impairs adaptive immunity in immune cells of patients with melanoma. Issue 1 (16th April 2020) Authors: Yoshida, Tatsuya; Ichikawa, Junya; Giuroiu, Iulia; Laino, Andressa S; Hao, Yuhan; Krogsgaard, Michelle; Vassallo, Melinda; Woods, David M; Stephen Hodi, F; Weber, Jeffrey Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 1(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Clinical impact of crizotinib on central nervous system progression in ALK-positive non-small lung cancer. (July 2016) Authors: Yoshida, Tatsuya; Oya, Yuko; Tanaka, Kosuke; Shimizu, Junichi; Horio, Yoshitsugu; Kuroda, Hiroaki; Sakao, Yukinori; Hida, Toyoaki; Yatabe, Yasushi Journal: Lung cancer Issue: Volume 97(2016) Page Start: 43 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Clinical outcomes of pembrolizumab therapy in advanced‐NSCLC patients with poor performance status (≥3) and high PD‐L1 expression (TPS ≥50%): A case series. Issue 12 (21st October 2020) Authors: Inaba‐Higashiyama, Ryoko; Yoshida, Tatsuya; Jo, Hitomi; Shirasawa, Masayuki; Motoi, Noriko; Ohe, Yuichiro Journal: Thoracic cancer Issue: Volume 11:Issue 12(2020) Page Start: 3618 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Clinical outcomes of platinum-based chemotherapy according to T790M mutation status in EGFR-positive non-small cell lung cancer patients after initial EGFR-TKI failure. (July 2017) Authors: Yoshida, Tatsuya; Kuroda, Hiroaki; Oya, Yuko; Shimizu, Junichi; Horio, Yoshitsugu; Sakao, Yukinori; Hida, Toyoaki; Yatabe, Yasushi Journal: Lung cancer Issue: Volume 109(2017) Page Start: 89 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗